Literature DB >> 4163779

Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs.

D M Davies, A MacIntyre, E J Millar, S M Bell, S K Mehra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4163779     DOI: 10.1016/s0140-6736(67)92898-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia?

Authors:  J R Taylor; H S Sherratt; D M Davies
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

Review 2.  Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  [Attempted suicide with glibenclamide].

Authors:  S Marigo; E T Cavallini; M Beltrami; F Signorelli
Journal:  Acta Diabetol Lat       Date:  1972 Sep-Oct

5.  Sulphonylureas and hypoglycaemia.

Authors:  R E Ferner; H A Neil
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

Review 6.  Problems and pitfalls of sulphonylurea therapy in older patients.

Authors:  D A Robertson; P D Home
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.